• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于负二项回归的样本量估计:比较随访时间不等时复发性事件的发生率

Sample Size Estimation for Negative Binomial Regression Comparing Rates of Recurrent Events with Unequal Follow-Up Time.

作者信息

Tang Yongqiang

机构信息

a GlaxoSmithKline , Research Triangle Park , North Carolina , USA.

出版信息

J Biopharm Stat. 2015;25(5):1100-13. doi: 10.1080/10543406.2014.971167. Epub 2014 Oct 16.

DOI:10.1080/10543406.2014.971167
PMID:25322146
Abstract

A sample size formula is derived for negative binomial regression for the analysis of recurrent events, in which subjects can have unequal follow-up time. We obtain sharp lower and upper bounds on the required size, which is easy to compute. The upper bound is generally only slightly larger than the required size, and hence can be used to approximate the sample size. The lower and upper size bounds can be decomposed into two terms. The first term relies on the mean number of events in each group, and the second term depends on two factors that measure, respectively, the extent of between-subject variability in event rates, and follow-up time. Simulation studies are conducted to assess the performance of the proposed method. An application of our formulae to a multiple sclerosis trial is provided.

摘要

推导了用于分析复发事件的负二项回归的样本量公式,其中受试者的随访时间可以不相等。我们得到了所需样本量的精确下限和上限,计算起来很容易。上限通常仅比所需样本量略大,因此可用于近似样本量。下限和上限可以分解为两项。第一项依赖于每组事件的平均数量,第二项取决于分别衡量事件发生率在受试者间变异程度和随访时间的两个因素。进行了模拟研究以评估所提出方法的性能。还提供了我们的公式在一项多发性硬化症试验中的应用。

相似文献

1
Sample Size Estimation for Negative Binomial Regression Comparing Rates of Recurrent Events with Unequal Follow-Up Time.用于负二项回归的样本量估计:比较随访时间不等时复发性事件的发生率
J Biopharm Stat. 2015;25(5):1100-13. doi: 10.1080/10543406.2014.971167. Epub 2014 Oct 16.
2
Blinded continuous monitoring in clinical trials with recurrent event endpoints.具有复发事件终点的临床试验中的盲法连续监测。
Pharm Stat. 2019 Jan;18(1):54-64. doi: 10.1002/pst.1907. Epub 2018 Oct 21.
3
Blinded sample size re-estimation for recurrent event data with time trends.具有时间趋势的复发事件数据的盲法样本量重新估计。
Stat Med. 2013 Dec 30;32(30):5448-57. doi: 10.1002/sim.5977. Epub 2013 Sep 16.
4
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.在一项为期1年的TRANSFORMS扩展研究中,复发缓解型多发性硬化症患者从肌肉注射干扰素β-1a转换为口服芬戈莫德对复发时间的影响。
Contemp Clin Trials. 2015 Mar;41:69-74. doi: 10.1016/j.cct.2014.12.011. Epub 2014 Dec 26.
5
Sample size for comparing negative binomial rates in noninferiority and equivalence trials with unequal follow-up times.在随访时间不等的非劣效性和等效性试验中比较负二项分布率的样本量。
J Biopharm Stat. 2018;28(3):475-491. doi: 10.1080/10543406.2017.1333998. Epub 2017 Aug 31.
6
A case study of modeling and exposure-response prediction for count data.
J Biopharm Stat. 2014;24(5):1073-90. doi: 10.1080/10543406.2014.929584.
7
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.复发缓解型多发性硬化症基于磁共振成像的临床试验:基于纵向模型的新样本量计算
Mult Scler. 2012 Nov;18(11):1600-8. doi: 10.1177/1352458512444326. Epub 2012 Apr 11.
8
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.那他利珠单抗停药后,芬戈莫德对比干扰素β/那他珠单抗治疗多发性硬化症的疗效。
Brain. 2015 Nov;138(Pt 11):3275-86. doi: 10.1093/brain/awv260. Epub 2015 Sep 11.
9
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design.复发缓解型多发性硬化症中年度复发率的趋势及其对临床试验设计的影响。
Mult Scler. 2011 Oct;17(10):1211-7. doi: 10.1177/1352458511406309. Epub 2011 May 17.
10
Sample size calculation for comparing two negative binomial rates.比较两个负二项分布率的样本量计算。
Stat Med. 2014 Feb 10;33(3):376-87. doi: 10.1002/sim.5947. Epub 2013 Aug 23.

引用本文的文献

1
Determining the optimal dose of reactive balance training after stroke: study protocol for a pilot randomised controlled trial.确定中风后反应性平衡训练的最佳剂量:一项试点随机对照试验的研究方案
BMJ Open. 2020 Aug 26;10(8):e038073. doi: 10.1136/bmjopen-2020-038073.
2
How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodology.为何以及如何将钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂作为糖尿病视网膜病变的潜在治疗选择进行探索:临床概念与方法
Ther Adv Endocrinol Metab. 2019 Dec 11;10:2042018819891886. doi: 10.1177/2042018819891886. eCollection 2019.
3
Does perturbation-based balance training prevent falls among individuals with chronic stroke? A randomised controlled trial.
基于扰动的平衡训练能否预防慢性中风患者跌倒?一项随机对照试验。
BMJ Open. 2018 Aug 17;8(8):e021510. doi: 10.1136/bmjopen-2018-021510.
4
Perturbation training to promote safe independent mobility post-stroke: study protocol for a randomized controlled trial.用于促进中风后安全独立移动能力的扰动训练:一项随机对照试验的研究方案
BMC Neurol. 2015 Jun 6;15:87. doi: 10.1186/s12883-015-0347-8.